Literature DB >> 8061808

Deterioration of mixed cryoglobulinemia during treatment with interferon-alpha-2a.

I Bojić1, D Lilić, C Radojcić, P Mijusković.   

Abstract

A 60-year-old female developed mixed cryoglobulinemia associated with liver cirrhosis caused by the hepatitis C virus. During treatment with rIFN-alpha-2a, deterioration of cryoglobulinemia was recognized. The possible mechanisms underlying the deterioration are discussed.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8061808     DOI： 10.1007/bf02358379

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN： 0944-1174            Impact factor:   7.527


  13 in total

Review 1.  Interferons: pleiotropic cellular modulators.

Authors:  E C Borden
Journal:  Clin Immunol Immunopathol       Date:  1992-01

2.  Mixed cryoglobulinemia responsive to interferon-alpha.

Authors:  T A Knox; C D Hillyer; M M Kaplan; E M Berkman
Journal:  Am J Med       Date:  1991-11       Impact factor: 4.965

3.  The spectrum of vasculitis: clinical, pathologic, immunologic and therapeutic considerations.

Authors:  A S Fauci; B Haynes; P Katz
Journal:  Ann Intern Med       Date:  1978-11       Impact factor: 25.391

4.  Nature of cryoglobulinaemia.

Authors:  Y Levo
Journal:  Lancet       Date:  1980-02-09       Impact factor: 79.321

5.  Type II essential mixed cryoglobulinaemia: presentation, treatment and outcome in 13 patients.

Authors:  A H Frankel; D R Singer; C G Winearls; D J Evans; A J Rees; C D Pusey
Journal:  Q J Med       Date:  1992-02

6.  Effect of alpha-interferon on hepatitis C virus chronic infection in mixed cryoglobulinemia patients.

Authors:  C Ferri; A L Zignego; G Longombardo; M Monti; L La Civita; F Lombardini; F Greco; A Mazzoni; G Pasero; P Gentilini
Journal:  Infection       Date:  1993 Mar-Apr       Impact factor: 3.553

7.  Interferon-alpha and interferon-gamma as regulators of human adult and newborn B-cell function.

Authors:  J Punnonen; M K Viljanen
Journal:  Int J Immunopharmacol       Date:  1989

8.  Treatment of idiopathic mixed cryoglobulinemia with alpha interferon.

Authors:  L Bonomo; M Casato; A Afeltra; D Caccavo
Journal:  Am J Med       Date:  1987-10       Impact factor: 4.965

9.  Cryoglobulins in patients with acute hepatitis and inflammatory bowel disease.

Authors:  Y Levo
Journal:  Hepatogastroenterology       Date:  1982-12

10.  Neutralizing antibodies to interferon-alpha: relative frequency in patients treated with different interferon preparations.

Authors:  G Antonelli; M Currenti; O Turriziani; F Dianzani
Journal:  J Infect Dis       Date:  1991-04       Impact factor: 5.226
View more
  4 in total

1.  Fatal exacerbation of hepatitis C-related cryoglobulinemia with interferon-alpha therapy.

Authors:  G Friedman; S Mehta; A H Sherker
Journal:  Dig Dis Sci       Date:  1999-07       Impact factor: 3.199

Review 2.  Tolerability of treatments for viral hepatitis.

Authors:  A Gervais; N Boyer; P Marcellin
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 3.  Cytokine-induced autoimmune disorders.

Authors:  P Miossec
Journal:  Drug Saf       Date:  1997-08       Impact factor: 5.606

Review 4.  Vasculitic complications of interferon-alpha treatment for chronic hepatitis C virus infection: case report and review of the literature.

Authors:  Wilke Beuthien; Hans-Ullrich Mellinghoff; Johannes von Kempis
Journal:  Clin Rheumatol       Date:  2005-06-30       Impact factor: 3.650
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.